Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3719-3725

  Fast, Søren ^a   Hegedüs, Laszlo ^a   Grupe, Peter ^a   Nielsen, Viveque Egsgaard ^a   Bluhme, Christa ^a   Bastholt, Lars ^a   Bonnema, Steen Joop ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PLACEBO; RECOMBINANT THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; EYE DISEASE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTHYROIDISM; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; MYXEDEMA; NODULAR GOITER; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOACTIVITY; RANDOMIZED CONTROLLED TRIAL; THYROID GLAND; THYROID WEIGHT;

EID: 77955367523     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0634     Document Type: Article

References (25)

1. Hegedüs L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132 (Pubitemid 36223282)
2. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton Jr CR, Zeiger MA, Zini M; AACE/AME Task Force on Thyroid Nodules 2006 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-102
3. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
4. Wesche MF, Tiel-V Buul MM, Lips P, Smits NJ, Wiersinga WM 2001 A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998-1005 (Pubitemid 32322972)
5. Fast S, Bonnema SJ, Hegedüs L 2008 The majority of Danish nontoxic goitre patients are ineligible for levothyroxine suppressive therapy. Clin Endocrinol (Oxf) 69:653-658
6. Hegedüs L, Hansen BM, Knudsen N, Hansen JM 1988 Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 297:661-662
7. Huysmans DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW 1994 Large, compressive goiters treated with radioiodine. Ann Intern Med 121:757-762
8. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Søe-Jensen P, Hansen JM 1993 Radioiodine treatment of multinodular non-toxic goitre. BMJ 307:828-832 (Pubitemid 23281746)
9. Fast S, Nielsen VE, Bonnema SJ, Hegedüs L 2009 Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 160:517-528
10. Nielsen VE, Bonnema SJ, Boel-Jørgensen H, Veje A, Hegedüs L 2005 Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 90:79-83 (Pubitemid 40116637)
11. Bonnema SJ, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Bastholt L, Hegedüs L 2007 Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 92:3424-3428 (Pubitemid 47435314)
12. Nielsen VE, Bonnema SJ, Boel-Jørgensen H, Grupe P, Hegedüs L 2006 Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 166:1476-1482 (Pubitemid 44125866)
13. Silva MN, Rubió IG, Romão R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G 2004 Administration of a single dose of recombinanthumanthyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 60:300-308 (Pubitemid 38297119)
14. Nieuwlaat WA, Huysmans DA, van den Bosch HC, Sweep CG, Ross HA, Corstens FH, Hermus AR 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129 (Pubitemid 36877482)
15. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, Hegedüs L 1999 The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 84:3636-3641 (Pubitemid 30645217)
16. Le Moli R, Wesche MF, Tiel-Van Buul MM, Wiersinga WM 1999 Determinants of long-term outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf) 50:783-789 (Pubitemid 29284513)
17. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM 1983 The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260-263 (Pubitemid 13184359)
18. Nielsen VE, Bonnema SJ, Hegedüs L 2004 Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab 89:2242-2247 (Pubitemid 38619859)
19. Bonnema SJ, Andersen PB, Knudsen DU, Hegedüs L 2002 MR imaging of large multinodular goiters: observer agreement on volume versus observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol 179:259-266 (Pubitemid 34694847)
20. Fast S, Nielsen VE, Grupe P, Bonnema SJ, Hegedüs L 2009 Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. J Nucl Med 50:732-737
21. de Klerk JM, van Isselt JW, van Dijk A, Hakman ME, Pameijer FA, Koppeschaar HP, Zelissen PM, van Schaik JP, van Rijk PP 1997 Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 38:372-376
22. Albino CC, Mesa Jr CO, Olandoski M, Ueda CE, Woellner LC, Goedert CA, Souza AM, Graf H 2005 Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 90:2775-2780 (Pubitemid 40686323)
23. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA 2001 Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 86:5330-5336 (Pubitemid 33070255)
24. Nygaard B, Faber J, Hegedüs L 1994 Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Clin Endocrinol (Oxf) 41:715-718
25. Fast S, Nielsen VE, Bonnema SJ, Hegedüs L 2010 Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0.1, 0.3 and 0.9 mg of rhTSH. Clin Endocrinol (Oxf) 72:411-416